✦ LIBER ✦

Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans

✍ Scribed by Leonid S. Metelitsa

Book ID: 113541903
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 904 KB
Volume: 140
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2010.10.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The characteristics of human NKT cells i

The characteristics of human NKT cells in lung cancer—CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients

✍ Jun Konishi; Koichi Yamazaki; Hiroshi Yokouchi; Naofumi Shinagawa; Kazuya Iwabuc 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Positive and negative interaction of 1,2

Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis

✍ Carina Danielsson; Hans Törmä; Anders Vahlquist; Carsten Carlberg 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 1 views

The natural ligands of the nuclear receptors vitamin D receptor (VDR) and retinoic acid receptor (RAR), i.e., 1␣,25dihydroxyvitamin D 3 (VD) and all-trans retinoic acid, have important effects on the proliferation, differentiation and apoptosis of a variety of malignant cells, including melanoma. Th

Activation of human Vα24NKT cells by α-g

Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner

✍ Mie Nieda; Andrew Nicol; Yasuhiko Koezuka; Akiko Kikuchi; Tsuyoshi Takahashi; Hi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Low TCR avidity and lack of tumor cell r

Low TCR avidity and lack of tumor cell recognition in CD8+T cells primed with the CEA-analogue CAP1-6D peptide

✍ Manuela Iero; Paola Squarcina; Pedro Romero; Philippe Guillaume; Elisa Scarselli 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 664 KB

Ki-1 (CD30) antigen is released by Ki-1-

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

✍ Olivera Josimovic-Alasevic; Horst Dürkop; Roland Schwarting; Eva Backé; Harald S 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

Ki-1 (CD30) antigen is released by Ki-l-positive tumor cells in vitro and in vivo I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay\* An enzyme-linked immunosorbent assay (ELISA) has been

G2.1 Earthworm leukocytes (CD11a+, CD45R

G2.1 Earthworm leukocytes (CD11a+, CD45RA+, β2-m+, Thy-1+) can kill human K562 tumor cell targets: E. L. Cooper1,2, M. M. Suzuki1, A. Cossarizza2, S. Salvioli2, M. Capri2, D. Quaglino2, I. Pasquali-Ronchetti2, C. Franceschi2 1Lab. of Comparative Immunology, Dept. of Anatomy and Cell Biology, University of California, Los Angeles, CA 90024, USA, 2Section of General Pathology, Dept. of Biomedical Sciences, University of Modena, Modena 41 100, Italy

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 66 KB